Occurrence of death within 30 days of a specified event or condition (serum/plasma-based quantitative measurement of mortality risk)
This test evaluates the likelihood of death occurring within 30 days after a medical event, such as hospitalization or surgery. It is not a direct blood test but rather an analysis of clinical data and risk factors.
["Assesses short-term mortality risk based on patient history and lab data."]
Key facts at a glance
- LOINC
- 111925-4
- Short code
- Death occurence period 30D Endscpy
- Synonyms
- Death occurence period 30D Endscpy
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- endoscopy
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
This test does not involve drawing blood directly. Instead, it uses a combination of patient history, clinical data, and sometimes lab results (such as those from serum/plasma) to calculate the probability of death within 30 days. It helps healthcare providers identify patients at higher risk for complications or death shortly after a medical event.
How It’s Used in Healthcare
Healthcare providers use this test to prioritize care for patients at higher risk of adverse outcomes. It may be used after surgeries, hospitalizations, or other high-risk medical events to guide treatment plans, resource allocation, or monitoring.
Why It Matters for You
While this test doesn’t provide a direct measure of your health, it helps doctors assess whether you’re at greater risk of complications after a medical procedure or event. Early identification of risk can lead to more aggressive or tailored interventions to improve outcomes.
Common Scenarios for This Test
This test is often performed in patients who have recently undergone surgery, been hospitalized for a serious illness, or are experiencing conditions that increase the risk of complications. It may also be used in research or clinical trials to evaluate outcomes.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test serves as a risk stratification tool, helping clinicians identify patients who may need closer monitoring, additional interventions, or adjustments to their care plan. It complements other diagnostic tools by providing a quantitative estimate of mortality risk, which can inform decisions about discharge planning, palliative care, or further investigations.
Short name
Death Risk in 30 Days
Frequently asked questions
What does this test involve?
How long will I need to wait for results?
Can this test be used for routine health checks?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy